Warning signs include shakiness, sweating, confusion, rapid heartbeat, dizziness, or extreme hunger
From January to April 2025, the average monthly switching rate to a different drug was 0.6% for AOM tirzepatide and 2.3% for AOM semaglutide
Because GLP-3 Reta engages an extra pathway, it has the potential to deliver greater metabolic benefits
The Big Question: Does Humana Cover Ozempic for Weight Loss
The purpose of this paper is to critically examine the inconsistencies of currently published data, examine the appropriateness of the current guidelines and to further educate anesthesiologists on the importance of informed perioperative assessment and management of these patients
Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, OBrien PC, et al